During the three and nine months ended September 30, 2026, the Company incurred restructuring costs of $12.9 million and $23.3 million, respectively, as part of the broader efforts to optimize the Company’s cost structure. The restructuring costs primarily consisted of severance payments, employee benefits, contract termination costs, and exit charges associated with the closure of facilities and related costs. The Company expects to substantially complete these actions in 2026, subject to local law and consultation requirements in certain countries. The Company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur as a result of or in connection with the implementation of these actions.

The following table summarizes the Company’s restructuring costs that were recorded as an operating expense in the accompanying Condensed Consolidated Statements of Operations during the three and nine months ended September 30, 2026 and 2025 (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025
Cost of revenues	$	566	$	407	$	3,120	$	2,091
Research and development	1,161		1,578		2,198		4,474
Sales and marketing	10,169		328		14,993		4,241
General and administrative	1,005		153		2,941		1,563
Total restructuring costs	$	12,901	$	2,466	$	23,252	$	12,369

The following table summarizes the Company’s restructuring liability that is included in accrued liabilities in the accompanying Condensed Consolidated Balance Sheets (in thousands):


Balance as of December 31, 2025	$	2,834
Restructuring costs	23,252
Cash payments	(21,585)
Non-cash and other adjustments	(852)
Balance as of September 30, 2026	$	3,649